Sunday, September 29, 2024
HomeTagsBlueSphere Bio

BlueSphere Bio

BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial

BlueSphere Bio, a drug development company focused on novel T-cell receptor (TCR) based therapies for oncology and non-oncology indications, announced a collaboration with NMDP...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics